Clincosm LogoSign in Get a demo

lung cancer

Showing 1 - 25 of 2,313
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lung Cancer, Patient Engagement, Research, Communication Trial in Oxford (Research readiness tool)

Not yet recruiting
  • Lung Cancer
  • +4 more
  • Research readiness tool
  • Oxford, Oxfordshire, United Kingdom
    Faculty of Health and Life Sciences, Oxford Brookes University
Mar 21, 2023

Lung Cancer Trial in Copenhagen (Resistance training)

Not yet recruiting
  • Lung Cancer
  • Resistance training
  • Copenhagen, Denmark
    University Hospital of Copenhagen
Mar 17, 2023

ARtificial Intelligence for Gross Tumour vOlume Segmentation

Recruiting
  • Lung Cancer
  • Radiotherapy
  • Maastricht, Limburg, Netherlands
    Maastro Clinic
Mar 7, 2023

Lung Cancer, Sarcopenia Trial in Beijing (soy protein, whey protein, )

Not yet recruiting
  • Lung Cancer
  • Sarcopenia
  • soy protein
  • +2 more
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Mar 5, 2023

Amino Acid Deficiency, Malnutrition, Lung Cancer Trial (amino acid tablet)

Not yet recruiting
  • Amino Acid Deficiency
  • +2 more
  • amino acid tablet
  • (no location specified)
Mar 14, 2023

Lung Cancer, COPD (COPD) With Acute Lower Respiratory Infection, Cardiovascular Diseases Trial in Milano (early lung cancer

Recruiting
  • Lung Cancer
  • +2 more
  • early lung cancer detection
  • blood test
  • Milano, MI, Italy
    Chiara Bovolenta
Mar 13, 2023

Lung Cancer Trial in Hong Kong (Low dose CT thorax)

Recruiting
  • Lung Cancer
  • Low dose CT thorax
  • Hong Kong, Hong Kong
    University of Hong Kong
Mar 6, 2023

Determining Clinical Trial Experiences of Lung Cancer Patients

Not yet recruiting
  • Lung Cancer
    • (no location specified)
    Feb 25, 2023

    Lung Cancer, Immune Checkpoint Inhibitor, Radiotherapy Trial in Chongqing (Super-hyperfractionation Pulse Radiotherapy)

    Recruiting
    • Lung Cancer
    • +2 more
    • Super-hyperfractionation Pulse Radiotherapy
    • Chongqing, Chongqing, China
    • +1 more
    Feb 22, 2023

    Lung Cancer, Lung Cancer Screening Trial in Seattle (Stepped Reminders, Patient Education)

    Enrolling by invitation
    • Lung Cancer
    • Lung Cancer Screening
    • Stepped Reminders
    • Patient Education
    • Seattle, Washington
      Kaiser Permanente
    Feb 17, 2023

    Plasma Proteomic Biomarkers for Early Diagnosis of Lung Cancer

    Recruiting
    • Lung Cancer
    • Plasma protein biomarker analysis
    • Hangzhou, China
      2nd Affiliated Hospital, School of Medicine, Zhejiang University
    Feb 23, 2023

    Augmented Endobronchial Ultrasound With Artificial Intelligence

    Recruiting
    • Artificial Intelligence
    • +2 more
    • machine learning algorithm
    • Levanger, Norway
    • +1 more
    Feb 13, 2023

    Lung Cancer, Tuberculosis, Pneumonia Trial in Russian Federation (Virtual bronchoscopy navigation, radial EBUS)

    Recruiting
    • Lung Cancer
    • +2 more
    • Virtual bronchoscopy navigation
    • radial EBUS
    • Chelyabinsk, Russian Federation
    • +5 more
    Feb 13, 2023

    Lung Cancer Trial (Centipeda minima+PD-1/PD-L1 inhibitor, PD-1/PD-L1 inhibitor)

    Not yet recruiting
    • Lung Cancer
    • Centipeda minima+PD-1/PD-L1 inhibitor
    • PD-1/PD-L1 inhibitor
    • (no location specified)
    Feb 17, 2023

    Lung Cancer, Thoracic Cancer, Lung Tumor Trial in Hamilton (Medtronic Signia Stapler, Da Vinci Vessel Sealer Extend Energy

    Not yet recruiting
    • Lung Cancer
    • +2 more
    • Medtronic Signia Stapler
    • Da Vinci Vessel Sealer Extend Energy Device with SureForm Stapling
    • Hamilton, Ontario, Canada
      St. Joseph's Healthcare Hamilton
    Feb 13, 2023

    Lung Cancer Trial in Singapore (Low-dose CT of the Chest (LDCT) + Sampling for Biomarker Assays)

    Recruiting
    • Lung Cancer
    • Low-dose CT of the Chest (LDCT) + Sampling for Biomarker Assays
    • Singapore, Singapore
    • +2 more
    Feb 1, 2023

    Lung Cancer Trial in Italy (Canakinumab, Placebo)

    Terminated
    • Lung Cancer
    • Rozzano, Milano, Italy, Italy
    • +5 more
    Feb 9, 2023

    Stratification for Hospital-diagnosed Advanced Lung Cancer

    Not yet recruiting
    • Lung Cancer
      • (no location specified)
      Feb 1, 2023

      Breast Cancer, Colon Cancer, Lung Cancer Trial in Tucson (Automated Telephone Symptom Management (ATMS) and Telephone

      Not yet recruiting
      • Breast Cancer
      • +4 more
      • Automated Telephone Symptom Management (ATMS) and Telephone Interpersonal Counseling (TIP-C)
      • Active control comparator
      • Tucson, Arizona
        University of Arizona Cancer Center
      Feb 6, 2023

      Breast Cancer, Comorbidities and Coexisting Conditions, Lung Cancer Trial (GERONTE)

      Not yet recruiting
      • Breast Cancer
      • +4 more
      • GERONTE
      • (no location specified)
      Jan 31, 2023

      Lung Cancer Trial (mixed reality guided localization)

      Not yet recruiting
      • Lung Cancer
      • mixed reality guided localization
      • (no location specified)
      Jan 27, 2023

      Lung Cancer, Lung; Node Trial (CT scans 2D Reconstruction, CT scans 2D plus 3D Reconstruction)

      Not yet recruiting
      • Lung Cancer
      • Lung; Node
      • CT scans 2D Reconstruction
      • CT scans 2D plus 3D Reconstruction
      • (no location specified)
      Jan 27, 2023

      Postoperative Outcomes in Primary Lung Cancer

      Completed
      • Lung Cancer
      • Nutridrink Compact Protein
      • Omsk, Russian Federation
      • +3 more
      Feb 2, 2023

      Prospective Procurement of Tumor Tissue to Identify Novel

      Enrolling by invitation
      • Solid Tumors
      • +7 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Feb 2, 2023

        Cancer, Solid Tumor, Melanoma Trial (KVA12123 - Dose Escalation, KVA12123 Plus Pembrolizumab - Dose Escalation, KVA12123 - Dose

        Not yet recruiting
        • Cancer
        • +16 more
        • KVA12123 - Dose Escalation
        • +3 more
        • (no location specified)
        Feb 2, 2023